Purity:SDS-PAGE

Anti-CD47 Reference Antibody (magrolimab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

Purity:SEC-HPLC

The purity of Anti-CD47 Reference Antibody (magrolimab) is 98.18%, determined by SEC-HPLC.

Research in vivo

Magrolimab inhibited the tumor growth of Raji on NOD.SCID mice. The result showed significant anti-tumor effects, with an tumor inhibition rate (TGI) of 90.0% at 5 mpk at D32.

-25~-15℃保存，有效期1年。